These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38978623)

  • 1. The m
    Yu S; Li C; Lu X; Han Z; Li Y; Yuan X; Guo D
    Front Endocrinol (Lausanne); 2024; 15():1426380. PubMed ID: 38978623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impacts of Non-coding RNAs and N
    Xu Z; Ji G; Cui Y; Cui X
    Curr Cancer Drug Targets; 2021; 21(5):375-385. PubMed ID: 33475064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding RNAs as therapeutic targets in autophagy-related diabetic cardiomyopathy.
    Break MKB; Syed RU; Hussein W; Alqarni S; Magam SM; Nawaz M; Shaikh S; Otaibi AA; Masood N; Younes KM
    Pathol Res Pract; 2024 Apr; 256():155225. PubMed ID: 38442448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the reciprocal regulation of m
    Yang J; Liang F; Zhang F; Zhao H; Gong Q; Gao N
    Pharmacol Ther; 2024 Jul; 259():108671. PubMed ID: 38830387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic and therapeutic perspectives of non-coding RNA-modulated apoptotic signaling in diabetic retinopathy.
    Wu Q; Liu C; Shu X; Duan L
    Cell Biol Toxicol; 2024 Jul; 40(1):53. PubMed ID: 38970639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
    Han J; Kong H; Wang X; Zhang XA
    Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into the interplay between m
    Yi YC; Chen XY; Zhang J; Zhu JS
    Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
    Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
    RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting non-coding RNAs and N
    Wu L; Zhang Y; Ren J
    Biochem Pharmacol; 2024 May; 223():116153. PubMed ID: 38513741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the cross-talk between N6-methyladenosine modification and non-coding RNAs in breast cancer: Mechanisms and clinical implications.
    Liu X; Xie X; Sui C; Liu X; Song M; Luo Q; Zhan P; Feng J; Liu J
    Int J Cancer; 2024 Jun; 154(11):1877-1889. PubMed ID: 38429857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Coding RNAs in Neurological and Neuropsychiatric Disorders: Unraveling the Hidden Players in Disease Pathogenesis.
    Ilieva MS
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Functions and Clinical Prospects of Extracellular Non-Coding RNAs in Diabetic Cardiomyopathy: an Updated Review.
    Yin Z; Chen C
    J Cardiovasc Transl Res; 2022 Jun; 15(3):469-476. PubMed ID: 35175553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ncRNAs-mediated pyroptosis in diabetes and its vascular complications.
    Feng X; Yang X; Zhong Y; Cheng X
    Cell Biochem Funct; 2024 Mar; 42(2):e3968. PubMed ID: 38439590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery.
    Pandey A; Ajgaonkar S; Jadhav N; Saha P; Gurav P; Panda S; Mehta D; Nair S
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research.
    Alharbi KS
    Pathol Res Pract; 2024 Feb; 254():155138. PubMed ID: 38266458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy.
    Zhang W; Xu W; Feng Y; Zhou X
    J Cell Mol Med; 2019 Sep; 23(9):5859-5867. PubMed ID: 31240820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs in diabetic peripheral neuropathy: their role and mechanisms underlying their effects.
    He Y; Qu L
    Metabolism; 2024 May; 154():155833. PubMed ID: 38462040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the crucial role of intercellular adhesion molecule-1 in secondary diabetic complications.
    Kaur P; Dahiya R; Nandave M; Sharma K; Goyal RK
    Cell Biochem Funct; 2024 Jun; 42(4):e4037. PubMed ID: 38736204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA as a regulator in the development of diabetic complications.
    Geng M; Liu W; Li J; Yang G; Tian Y; Jiang X; Xin Y
    Front Endocrinol (Lausanne); 2024; 15():1324393. PubMed ID: 38390204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.